Cryoport Inc
NASDAQ:CYRX
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Cryoport Inc
NASDAQ:CYRX
|
420.1m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.2B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.3B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.7B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Cryoport Inc
Glance View
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 791 full-time employees. The company went IPO on 2015-07-24. The firm provides supply chain technologies and services through its brands, such as Cryoport Systems, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. The firm's products include Cryoport Express Shippers, Cryoport ELITE Shippers, Cryoport Cryosphere, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature Controlled Logistics, CRYOPDP Direct to Patient Solutions, CRYOPDP Control Tower Solution, MVE Biological Solutions Fusion Cryogenic Freezers and MVE Biological Solutions Vario Cryogenic Freezer. The company operates primarily in Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Its subsidiaries include Cryoport Systems, LLC, Cryogene, Inc., MVE Biological Solutions, US LLC, Cryoport Netherlands B.V., and Cell&Co BioServices.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Cryoport Inc is 46.6%, which is above its 3-year median of 43.6%.
Over the last 3 years, Cryoport Inc’s Gross Margin has increased from 43.2% to 46.6%. During this period, it reached a low of 41.8% on Mar 31, 2024 and a high of 46.6% on Sep 30, 2025.
